Drawing for COVALENT

USPTO serial 88189534

COVALENT

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BEDNARZ, DUSTIN THOMAS
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with COVALENT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

J. Daniel Harkins

J. Daniel Harkins DYKEMA GOSSETT PLLC112 E. Pecan StreetSuite 1800San Antonio, TX 78205

Goods and services

ClassDescriptionStatusFirst use
044Medical radiology servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Dec 21, 2020MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 21, 2020ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 17, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 17, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 17, 2020EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jun 17, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 17, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 17, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 19, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 24, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 24, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 4, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 20, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 13, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 13, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 13, 2020ALIEASSIGNED TO LIE—
Feb 10, 2020ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Aug 21, 2019RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Feb 21, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Feb 21, 2019GNSLLETTER OF SUSPENSION E-MAILED—
Feb 21, 2019CNSLSUSPENSION LETTER WRITTEN—
Feb 14, 2019DOCKASSIGNED TO EXAMINER—
Nov 28, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 14, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance